Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies ; volume:15 ; number:1 ; day:30 ; month:3 ; year:2024 ; pages:1-19 ; date:12.2024
Nature Communications ; 15, Heft 1 (30.3.2024), 1-19, 12.2024
- Creator
-
Daneshmandi, Saeed
Choi, Jee Eun
Yan, Qi
MacDonald, Cameron R.
Pandey, Manu
Goruganthu, Mounika
Roberts, Nathan
Singh, Prashant K.
Higashi, Richard M.
Lane, Andrew N.
Fan, Teresa W-M
Wang, Jianmin
McCarthy, Philip L.
Repasky, Elizabeth A.
Mohammadpour, Hemn
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-47096-9
- URN
-
urn:nbn:de:101:1-2406171033450.496854365406
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Daneshmandi, Saeed
- Choi, Jee Eun
- Yan, Qi
- MacDonald, Cameron R.
- Pandey, Manu
- Goruganthu, Mounika
- Roberts, Nathan
- Singh, Prashant K.
- Higashi, Richard M.
- Lane, Andrew N.
- Fan, Teresa W-M
- Wang, Jianmin
- McCarthy, Philip L.
- Repasky, Elizabeth A.
- Mohammadpour, Hemn
- SpringerLink (Online service)
Other Objects (12)
Hematologic malignancies
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
Genomic testing for germline predisposition to hematologic malignancies
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future
Biomimetic Nanoparticles for the Treatment of Hematologic Malignancies
Hematologic malignancies
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
Genomic testing for germline predisposition to hematologic malignancies
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future
Biomimetic Nanoparticles for the Treatment of Hematologic Malignancies
Hematologic malignancies
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
Genomic testing for germline predisposition to hematologic malignancies
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future